Market Research Future (MRFR) has announced the release of a new market research report. The report analyzes the global medical morphine market and provides readers with forecasts for the 2017-2023 forecast period. According to the report, the global medical morphine market is expected to rise at a CAGR of 7.5% over the 2017-2023 forecast period.
Medical Morphine Market Overview:
Medical morphine is prescribed for conditions such as arthritis, cancer, and cardiovascular disorders. The increasing use of painkillers in combating these disorders is the main driver for the global medical morphine market. Cardiovascular disorders are among the deadliest diseases of the modern age, with the American Heart Association reporting that one in three deaths in the U.S. in 2014 was due to cardiovascular disorders. Cardiovascular diseases claimed over 800,000 lives in the U.S. in 2014, demonstrating their growing prevalence. As a result, medication to counter cardiovascular pain is becoming ever more prevalent. This is likely to be a major driver for the global medical morphine market, as pollution and lifestyle factors are likely to further drive the prevalence of cardiovascular diseases across the world in the coming years.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/6084
Arthritis is also among the most common diseases among the elderly across the world, with more than 30 million in the U.S. alone suffering from osteoarthritis in 2015. Arthritis is an inflammatory condition manifested mainly through painful joints. As a result, painkillers are among the primary medications prescribed for arthritis treatment and management. This is likely to boost the global medical morphine market over the forecast period, as medical morphine represents one of the most effective ways to counter arthritic pain currently available to medical science.
On the other hand, the risk of morphine addiction is likely to hinder the growth of the global medical morphine market over the forecast period. Morphine is an opioid and is thus a highly restricted substance. Opioid addiction is one of the biggest problems facing the developed world at present, but since opioids are the only naturally available painkillers known to man, their use is still rendered necessary. This has led to opioid addiction emerging as a serious threat to human wellbeing in the developed world over the last few decades. This is likely to lead to strict restrictions on the medical morphine market, curtailing its growth.
Medical Morphine Market Segmental Analysis:
The report segments the global medical morphine market by route of administration, distribution channel, application, end use, and region.
By route of administration, the global medical morphine market is segmented into oral and injected medical morphine.
Based on distribution channel, the medical morphine market is divided into hospital pharmacy, retail pharmacy, online pharmacy, and others.
Based on application, the medical morphine market is segmented into cancer, arthritis, kidney stones, myocardial infarction, diarrhea, and others.
By end use, the medical morphine market is segmented into home care, hospitals and clinics, and ambulatory surgical centers.
Medical Morphine Market Regional Analysis:
Geographically, the report segments the global medical morphine market into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa. The Americas segment is further segmented into North and South America, while the Europe segment is further divided into Western and Eastern Europe.
The Americas and Europe collectively account for more than 75% of the global medical morphine market and are likely to remain the largest regional segment of the market due to the high geriatric population in the region. Geriatric care is a major issue in countries such as the U.S., Canada, the UK, and France, which is likely to enable strong prospects for the medical morphine market in these regions over the forecast period. Increasing prevalence of cardiovascular diseases is likely to enable strong growth of the APAC market for medical morphine over the forecast period.
Medical Morphine Market Competitive Analysis:
Leading players in the global medical morphine market include Mallinckrodt Pharmaceuticals, Alcaliber S.A, Purdue Pharma L.P., Pfizer Inc., Johnson Matthey Fine Chemicals, Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Taj Pharmaceuticals Limited, NORTHEAST PHARM, and MANUS AKTTEVA BIOPHARMA LLP.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/medical-morphine-market-6084
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.